INTECH Investment Management’s Bioventus BVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$128K Sell
13,539
-2,810
-17% -$26.8K ﹤0.01% 1902
2026
Q1
$149K Sell
16,349
-11,885
-42% -$99.7K ﹤0.01% 1821
2025
Q4
$210K Sell
28,234
-4,151
-13% -$29.8K ﹤0.01% 1953
2025
Q3
$217K Sell
32,385
-10,708
-25% -$74.3K ﹤0.01% 2020
2025
Q2
$285K Buy
43,093
+10,480
+32% +$74.3K ﹤0.01% 1892
2025
Q1
$298K Buy
32,613
+8,248
+34% +$82.4K ﹤0.01% 1893
2024
Q4
$256K Buy
24,365
+10,384
+74% +$123K ﹤0.01% 1908
2024
Q3
$167K Buy
+13,981
New +$121K ﹤0.01% 1777

Other funds holding BVS

INTECH Investment Management's BVS Position: Q2 2026 in Review

INTECH Investment Management reduced its Bioventus (BVS) stake by 17% in Q2 2026, selling an estimated $26.8K and leaving 13,539 shares worth $128K. The position accounts for ﹤0.01% of the portfolio, ranked #1902.

INTECH Investment Management first reported a position in BVS in Q3 2024 and has held it in 8 quarters since. The position peaked at $298K in Q1 2025. 157 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • INTECH Investment Management held 13,539 shares of Bioventus worth $128K as of Q2 2026.
  • INTECH Investment Management sold 2,810 Bioventus shares in Q2 2026, an estimated $26.8K.
  • Bioventus made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1902 holding.
  • INTECH Investment Management first reported a position in Bioventus in Q3 2024 and has held it in 8 quarters since.
  • INTECH Investment Management's Bioventus position peaked at $298K in Q1 2025.
  • 157 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.